In this study we demonstrated that, in addition to the oxidative modifications and the loss of ferroxidase activity already reported [3–7], the ceruloplasmin in the CSF of PD patients undergoes to conformational changes and NGR-motifs deamidation, which in turn promote the gain of integrin-binding function. The gene discussed is CP; the disease is Parkinson disease.